General Contact

GlaxoSmithKline AS
Postboks 180 Vinderen
N-0319 Oslo
T: +47 22 70 20 00

Medical Information
& Drug Safety

T: +47 22 70 20 00
email medical information:
email adverse events reporting:

Product Information

Toctino (alitretinoin) is licensed in Norway. The product information on this site is intended for healthcare professionals only. Patients or non-healthcare persons should consult their own doctor or other medical professionals about the treatment and therapies.
If you need any further medical information or assistance, and you are a qualified healthcare professional, you may contact our Medical Information or Drug Safety center.